Cell Therapy Market is expected to reach US$ 12,563.23 Mn by 2027 Vericel Corporation; MEDIPOST; NuVasive, Inc.; Mesoblast Limited;

According to our new market research study on “Cell Therapy Market Forecast to 2027 – COVID-19 Impact and Global Analysis – by Therapy Type, Product, Technology, Application, and End User,” the market is expected to reach US$ 12,563.23 million by 2027 from US$ 7,260.50 million in 2019. It is estimated to grow at a CAGR of 7.2% from 2020–2027. The growth of the market is attributed to increasing prevalence of chronic diseases, rising adoption of regenerative medicines, and surging number of approvals for cell-based therapies. However, the high cost of cell therapy manufacturing hinders the growth of the market.

The cell therapy market, based on therapy type, is bifurcated into allogeneic and autologous. In 2019, the allogeneic segment accounted for a larger share owing to the availability of substantial number of approved products for clinical use. For instance, in 2018, Alofisel developed by TiGenix (Takeda) is the first allogeneic stem cell-based therapy approved for use in Europe.

Get Sample PDF Here >> https://www.theinsightpartners.com/sample/TIPRE00009666/

Vericel Corporation; MEDIPOST; NuVasive, Inc.; Mesoblast Limited; JCR Pharmaceuticals Co. Ltd.; Smith & Nephew; Bristol-Myers Squibb Company; Cells for Cells; Stemedica Cell Technologies, Inc; and Castle Creek Biosciences, Inc. are among the companies operating in the cell therapy market.

Strategic Insights

A few players operating in the cell therapy market are Vericel Corporation; MEDIPOST; NuVasive, Inc.; Mesoblast Limited; JCR Pharmaceuticals Co. Ltd.; Smith & Nephew; Bristol-Myers Squibb Company; Cells for Cells; Stemedica Cell Technologies, Inc; and Castle Creek Biosciences, Inc. These players are adopting several organic and inorganic strategies to enhance their revenue and market standings. For instance, in November 2019, MEDIPOST started the extension of its GMP manufacturing facility. The facility is anticipated to increase the sales of CARTISTEM and the development of a new pipeline of products.

 Cell Therapy Market– by Therapy Type

• Allogeneic
• Autologous

Cell Therapy Market– by Product

• Consumables
• Equipment
• Systems and Software

Cell Therapy Market– by Technology

• Viral Vector Technology
• Genome Editing Technology
• Somatic Cell Technology
• Cell Immortalization Technology
• Cell Plasticity Technology
• Three-Dimensional Technology

Cell Therapy Market– by Application

• Oncology
• Cardiovascular
• Orthopedic
• Wound Management
• Other Applications

Cell Therapy Market– by End User

• Research Institutes
• Hospitals
• Others

Cell Therapy Market – by Geography

• North America
• US
• Canada
• Mexico
• Europe
• France
• Germany
• Italy
• UK
• Spain
• Asia Pacific (APAC)
• China
• India
• South Korea
• Japan
• Australia
• Middle East and Africa (MEA)
• South Africa
• Saudi Arabia
• UAE
• South and Central America
• Brazil
• Argentina

 Purchase Full Copy of This Report @ https://www.theinsightpartners.com/buy/TIPRE00009666/